ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Immunogenicity"

  • 2019 American Transplant Congress

    Report of 20 HLAMatchmaker Eplets Present on Denatured Class I HLA Molecules

    R. de Marco1, A. C. Lima2, N. F. Pereira2, M. Gerbase-DeLima1

    1Immunogenetics Institute, AFIP, Sao Paulo, SP, Brazil, 2Immunogenetics Laboratory, Universidade Federal do Paraná, Curitiba, PR, Brazil

    *Purpose: The purpose of this report is to describe 20 class I HLA eplets, herein called FakEplets, present on denatured HLA molecules.*Methods: The study included…
  • 2019 American Transplant Congress

    Endothelial Cells Do Not Regulate Expression of CD46, CD55 and CD59 in the Presence of Anti-HLA Class I and 11 Antibodies

    A. Babu1, T. Pham2, M. Hamdorf2, V. Jucaud2, M. Everly2, S. Daga3, D. Mitchell4

    1Transplant Institute, Henry Ford Hospitals, Detroit, MI, 2Terasaki Research Institute, Los Angeles, CA, 3University of Warwick, Coventry, United Kingdom, 4Medical Sciences, University of Warwick, Coventry, United Kingdom

    *Purpose: Anti-HLA antibodies, both pre-formed and de novo are associated with worse graft survival. Complement activation is an important mechanism of antibody mediated immunological injury.…
  • 2019 American Transplant Congress

    The Response to Human Papillomavirus Vaccination in Pediatric Patients before and after Kidney Transplantation

    C. Nailescu1, R. D. Nelson2, K. Twombley3, P. S. Verghese4, A. S. Chishti5, M. Mills6, J. E. Slaven7, J. D. Mahan8, M. L. Shew1

    1Riley Hospital for Children, Indianapolis, IN, 2Primary Children’s Hospital, Salt Lake City, UT, 3MUSC Children’s Hospital, Charleston, SC, 4Children’s Hospitals and Clinics of Minnesota, Minneapolis, MN, 5Kentucky Children’s Hospital, Lexington, KY, 6C.S. Mott Children’s Hospital, Ann Arbor, MI, 7Indiana University, Indianapolis, IN, 8Nationwide Children’s Hospital, Columbus, OH

    *Purpose: Kidney transplant (KT) recipients have an increased incidence of malignancies, including Human Papillomavirus (HPV)-associated cancers. Thus, HPV vaccines may have an important role in…
  • 2019 American Transplant Congress

    Kidney Allografts Induce Systemic Tolerance of Heart Allografts and is Dependent on Foxp3+ Cells

    C. Yang1, J. Ge1, P. S. Russell1, J. C. Madsen1, A. Alessandrini1, R. B. Colvin2

    1Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA, 2Department of Pathology, Massachusetts General Hospital, Boston, MA

    *Purpose: We have successfully achieved cardiac allograft tolerance in both pigs and NHP by donor kidney co-transplantation. The mechanism of Kidney Induced Cardiac Allograft Tolerance…
  • 2018 American Transplant Congress

    Determining the Relative Immunogenicity of HLA Mismatches with Calcineurin Inhibitor Immunosuppression: An Analysis of the BENEFIT and BENEFIT-EXT Renal Transplant Cohort

    V. Jucaud,1 M. Roberts,2 H. Gebel,3 R. Bray,3 M. Everly.1

    1Terasaki Research Institute, Los Angeles, CA; 2Immunology Biomarker Group, Bristol-Myers Squibb, Princeton, NJ; 3Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, GA.

    We studied the relative immunogenicity of HLA-A, -B, -C, -DR and -DQ MM (serological) in a cohort of 291 kidney transplant patients from the BENEFIT…
  • 2018 American Transplant Congress

    Circulating Exosomes with Lung Self-Antigens, Kα1Tubulin and Collagen V, and Immune Regulatory Proteins in Lung Transplant Recipient with Primary Graft Dysfunction

    M. Sharma, S. Biswas Roy, R. Walia, A. Omar, R. Bremner, M. Smith, T. Mohanakumar.

    Norton Thoracic Institute, St. Joseph's Hospital & Medical Center, Phoenix.

    Background: Circulating exosomes isolated from lung transplant recipients (LTxRs) with acute or chronic rejection contains lung self-antigens (SAgs), K alpha 1 tubulin (Kα1T) and collagen…
  • 2018 American Transplant Congress

    Antibody-Verified Eplet Mismatches as Determinants of Premature Kidney Transplant Loss

    R. Sapir-Pichhadze,1 X. Zhang,1 A. Ferradji,1 A. Madbouly,2 S. Fingerson,2 K. Tinckam,5 H. Gebel,3 H. Cardinal,4 B. Foster.1

    1McGill University, Montreal, Canada; 2National Marrow Donor Program, Minneapolis; 3Emory University Hospital, Atlanta; 4CHUM, Montreal, Canada; 5University Health Network, Toronto, Canada.

    Introduction: HLA matching at the epitope level offers new opportunities to identify compatible donors for transplant candidates. HLAMatchmaker deduces B-cell epitope ('eplets' in HLAMatchmaker) mismatches…
  • 2018 American Transplant Congress

    Novel Function of TIE2 in Immunoregulation

    C. Ghosh, T. Agur, A-.L. Mak, S. Pal, J. Wedel, B. David.

    Transplant Research Program, Boston Children's Hospital, Boston, MA.

    The immunogenicity of graft microvascular endothelial cells (ECs) has immense biological significance in the modulation of the local intragraft microenvironment. EC may either support Teffector…
  • 2018 American Transplant Congress

    Rapamycin Impairs Human Endothelial Cell Alloimmunogenicity Independent of PD-1/PD-1 Ligand Inhibitory Signaling

    Q. Gao, V. Bendersky, A. Kirk, H. Xu.

    Department of Surgery, Duke University Medical Center, Durham, NC.

    Rapamycin prevents costimulation blockade (CoB)-resistant rejection in mice and primates, and early human data suggests a similar salutary effect. We have hypothesized that one mechanism…
  • 2018 American Transplant Congress

    Genome Wide Non-HLA Alloimmunity Contributes to Graft Loss after Kidney Transplantation

    R. Reindl-Schwaighofer, A. Heinzel, A. Kainz, K. Jelencsics, O. Viklicky, G. Böhmig, G. Fischer, B. Keating, R. Oberbauer.

    Division of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria; Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Transplant Institute, University of Pennsylvania, Philadelphia, PA.

    BackgroundChronic rejection is the main cause of renal transplant loss after the first year and has mostly been attributed to alloimmune responses against human leukocyte…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 13
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences